Another publication with Staburo biostatistics support, this time in diabetes type 2. Background: Studies of dipeptidyl peptidase (DPP)-4 inhibitors report heterogeneous effects on endothelial function in patients with type 2 diabetes (T2D). This study assessed the...

Staburo delivered biostatistics services in this bioavailability study. The development of several disorders, such as cardiovascular diseases, diabetes and osteoporosis, has been linked to suboptimal dietary magnesium (Mg) intake. In this context, a number of studies...

The Staburo SAS programming environment facilitates the creation of meaningful outputs, such as tables, listings and figures (TLFs), from client supplied data. This process consists of two key steps: From raw data to intermediate derived data: Data supplied by the...

We wish all our partners and future partners, all our employees and future employees, and all their families a wonderful Christmas and a great start in 2017. Staburo will continue to support you with experienced biostatisticians and statistical programmers next year...

This talk provided insight into the system of the AMNOG and the hurdles which have to be overcome in the assessment of a benefit, with focus on the statistical needs. In particular, the process at the German authorities “Gemeinsamer Bundesausschuss” (G-BA) and...

This year's Staburo Christmas party took place in the Barschule München, where we learned very much about famous Cocktails, its variants and how to produce them. We started the course with (single-)blinded sensorical testing of different alcoholic analytes, by...

Staburo took part in the APF workshop on 25 November 2016 in Berlin. This year, the APF has been invited by Parexel International GmbH. The APF is a German pharmaceutical research working group for statisticians in the pharmaceutical and healthcare industry, academia...

Staburo took part in this year's BVMA symposium on 25 November 2016, at the Sheraton München Arabellapark Hotel, here in Munich. The BVMA represents the interests of the German CROs. The member companies maintain a lively exchange of information on all topics which...

In this talk, important aspects of pharmacokinetics (PK) and pharmacodynamics (PD) were presented. Four elements of PK (ADME) were discussed in detail. Biopharmaceutical classification system (BCS), 2-compartment distribution model, destructive and conjugative...